Early safety, immune monitoring, and efficacy results from three patients enrolled in a Phase 2 trial of TGFÃŽÂ 2 RI inhibitor, LY2157299, with neoadjuvant 5-fluorouracil and radiation in patients with locally advanced rectal cancer

Immune Monitoring ◽

Phase 2 ◽

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00004-2 ◽

2015 ◽

Vol 16 (8) ◽

pp. 957-966 ◽

Cited By ~ 257

Author(s):

Julio Garcia-Aguilar ◽

Oliver S Chow ◽

David D Smith ◽

Jorge E Marcet ◽

Peter A Cataldo ◽

...

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Neoadjuvant Chemoradiation ◽

Phase 2 ◽

Multicentre Phase ◽

The Synergistic Capacity of Modulated Electro-Hyperthermia in Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer: An Interim Report of Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.988 ◽

2017 ◽

Vol 99 (2) ◽

pp. E162 ◽

Cited By ~ 1

Author(s):

S. Kim ◽

S.H. You ◽

J. Cha ◽

J.Y. Lee

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Preoperative Chemoradiation Therapy

Preoperative Chemoradiation ◽

Chemoradiation Therapy ◽

Phase 2 ◽

Interim Report ◽

Phase 2 Trial ◽

Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12

Annals of Oncology ◽

10.1093/annonc/mdz154.010 ◽

2019 ◽

Vol 30 ◽

pp. iv129 ◽

Cited By ~ 1

Author(s):

R. Hofheinz ◽

E. Fokas ◽

M. Allgäuer ◽

B. Polat ◽

G. Klautke ◽

...

Keyword(s):

Rectal Cancer ◽

Neoadjuvant Therapy ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 2 ◽

Consolidation Chemotherapy ◽

Phase 2 Trial ◽

Total Neoadjuvant Therapy ◽

Randomized Phase 2

Feasibility of modulated electro-hyperthermia as a concomitant boost to preoperative radiotherapy in locally advanced rectal cancer: A phase 2 trial

Annals of Oncology ◽

10.1093/annonc/mdz155.370 ◽

2019 ◽

Vol 30 ◽

pp. iv102

Author(s):

S. Kim ◽

S. You ◽

J. Cha ◽

J. Lee

Keyword(s):

Rectal Cancer ◽

Preoperative Radiotherapy ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 2 ◽

Phase 2 Trial ◽

Concomitant Boost

Neoadjuvant Sandwich Treatment With Oxaliplatin and Capecitabine Administered Prior to, Concurrently With, and Following Radiation Therapy in Locally Advanced Rectal Cancer: A Prospective Phase 2 Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.07.021 ◽

2014 ◽

Vol 90 (5) ◽

pp. 1153-1160 ◽

Cited By ~ 24

Author(s):

Yuan-Hong Gao ◽

Jun-Zhong Lin ◽

Xin An ◽

Jie-Lin Luo ◽

Mu-Yan Cai ◽

...

Keyword(s):

Rectal Cancer ◽

Radiation Therapy ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Phase 2 ◽

Phase 2 Trial ◽

Prospective Phase

Phase 2 Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-FU, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: ECOG 3204

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.302 ◽

2015 ◽

Vol 93 (3) ◽

pp. S126-S127

Author(s):

R.S. Prabhu ◽

Y. Feng ◽

J.C. Landry ◽

S.J. Cohen ◽

C.A. Staley ◽

...

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Preoperative Radiation ◽

Phase 2 ◽

Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2018.08.027 ◽

2018 ◽

Vol 129 (2) ◽

pp. 300-305 ◽

Cited By ~ 4

Author(s):

Xin Wang ◽

Yongyang Yu ◽

Wenjian Meng ◽

Dan Jiang ◽

Xiangbing Deng ◽

...

Keyword(s):

Risk Factors ◽

Rectal Cancer ◽

High Risk ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Rectal Cancer ◽

Phase 2 ◽

High Risk Factors ◽

Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: a phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30762-3 ◽

2017 ◽

Vol 18 ◽

pp. S6 ◽

Cited By ~ 1

Author(s):

Xin Wang ◽

Yongyang Yu ◽

Xiangbing Deng ◽

Wenjian Meng ◽

Hong Zhu ◽

...

Keyword(s):

Risk Factors ◽

Rectal Cancer ◽

High Risk ◽

Locally Advanced ◽

Neoadjuvant Treatment ◽

Advanced Rectal Cancer ◽

Phase 2 ◽

High Risk Factors ◽

Preoperative Chemoradiation With a Simultaneous Integrated Boost Compared to Regular Preoperative Chemoradiation for Locally Advanced Rectal Cancer: Interim Analysis of a Randomized Phase 2 Trial (NCT02195141)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.303 ◽

2015 ◽

Vol 93 (3) ◽

pp. S127

Author(s):

H. Ren ◽

Y. Tang ◽

J. Jin ◽

N. Li ◽

H. Fang ◽

...

Keyword(s):

Rectal Cancer ◽

Interim Analysis ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Preoperative Chemoradiation ◽

Phase 2 ◽

Phase 2 Trial ◽

Integrated Boost ◽

Randomized Phase 2

Faculty Opinions recommendation of Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717976179.793473142 ◽

2013 ◽

Author(s):

Yiqian Nancy You ◽

Brian Keith Bednarski

Keyword(s):

Rectal Cancer ◽

Locally Advanced ◽

Advanced Rectal Cancer ◽

Preoperative Radiation ◽

Phase 2 ◽

Phase 2 Study